Stroke News and Research

RSS
A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.
Insuring your health: Health law expands Medicare coverage of preventive care

Insuring your health: Health law expands Medicare coverage of preventive care

Omeros net loss for second-quarter 2010 increases to $7.8 million

Omeros net loss for second-quarter 2010 increases to $7.8 million

Noven enters agreement to acquire global rights to ADHD drug Daytrana from Shire

Noven enters agreement to acquire global rights to ADHD drug Daytrana from Shire

Graymark Healthcare second-quarter consolidated net revenues increase 12% to $28.3 million

Graymark Healthcare second-quarter consolidated net revenues increase 12% to $28.3 million

DynaVox releases software Version 2.0 for Xpress communication device

DynaVox releases software Version 2.0 for Xpress communication device

First Edition: August 10, 2010

First Edition: August 10, 2010

New method for tracing brain circuits

New method for tracing brain circuits

Older Americans suffer from full-blown depression: Report

Older Americans suffer from full-blown depression: Report

CGI receive contract for chronic disease management system

CGI receive contract for chronic disease management system

Athersys second-quarter revenues increase to $1.9 million

Athersys second-quarter revenues increase to $1.9 million

CytRx reports net income for second-quarter 2010 compared to net loss for previous year

CytRx reports net income for second-quarter 2010 compared to net loss for previous year

Research Roundups: Expanding Medicaid; More spending doesn't reduce mortality; Colonoscopy cost effectiveness; Kids, asthma and access to care

Research Roundups: Expanding Medicaid; More spending doesn't reduce mortality; Colonoscopy cost effectiveness; Kids, asthma and access to care

JumpStart Ventures announces investment commitment of $250,000 in ChanRx

JumpStart Ventures announces investment commitment of $250,000 in ChanRx

Need for trained medical professionals to treat medical emergencies in high school athletes

Need for trained medical professionals to treat medical emergencies in high school athletes

Vyvanse Capsules CII demonstrates significant improvement in adults with ADHD: Phase 3b study

Vyvanse Capsules CII demonstrates significant improvement in adults with ADHD: Phase 3b study

Eliminating depression, diabetes can reduce levels of dementia: Study

Eliminating depression, diabetes can reduce levels of dementia: Study

Affymax, Takeda announce preliminary strategy for Hematide to treat anemia in chronic renal failure patients

Affymax, Takeda announce preliminary strategy for Hematide to treat anemia in chronic renal failure patients

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Micrus Endovascular first-quarter fiscal 2011 total revenues increase 16% to $24.6 million

Micrus Endovascular first-quarter fiscal 2011 total revenues increase 16% to $24.6 million

Kaiser Permanente funds 700 grants targeting critical health issues in communities

Kaiser Permanente funds 700 grants targeting critical health issues in communities

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.